Narrow Outlet

No problem. This fine journalist's previous column was about the miracle of the pharmaceutical industry, with choice quotes like: "Increase profits by decreasing quality and you risk driving your customer into the arms of your competitor."
Unfortunately, Myron wasn't on hand to correct that particular lie by reminding him of that other government private property rights register: The Patent, which ensures there is no competitor.
Not to worry, he swiped at public opinion which held that drugs were too expensive: "How [do] these [armchair] pharmacists know the research and development cost of even one pill?"
Presumably by reading the profit figures, which by definition are not research spending. He ended the column with the gem: "...good intentions will not even finance the manufacturing of an aspirin."
I thought we were talking about research and development.
The telling of lies does frequently get sloppy, because the correction mechanism is not referal to independent facts, evidence, history, or reasoned argument, you have to go back to the source to get the false story straight. That's what the corporate spokesman are there for.
Real reporters know this, and don't report their words uncritically verbatim. They ask questions. So, when the spokesman says: "[With price controls] France [produces] only 4 percent of world's new medicines," a reporter would ask to see the list of pills from which this 4% figure is derived. He would check that it didn't include all the killer drugs that were taken off the market because they were dangerous and didn't do anything medically new.
A long as Myron only takes interviews with people of this calibre, we're making progress. It won't be long till Exxon fires him for preaching only to the choir.
0 Comments:
Post a Comment
<< Home